AbbVie, Inc. (ABBV)
223.43
+4.41
(+2.01%)
USD |
NYSE |
Feb 06, 16:00
223.20
-0.23
(-0.10%)
Pre-Market: 20:00
AbbVie SG&A Expense (TTM) : 14.01B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 7.05B |
| Biogen, Inc. | 2.434B |
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.68B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |